Munich Re to stop pandemic event cancellation cover
December 9 2020 by Yvonne Lau
-
Opinion: Mpox cases with deadlier strain send jitters across Asian P&C market
- August 27
While the number of cases is still limited in the region, a potential spreading of the virus, especially the mutated clade 1b strain, could disrupt fragile supply chains already impacted by the curtailment of shipping in the Red Sea and result in potential BI losses.
-
Opinion: WHO’s call for concerted push to prepare for next pandemic a timely warning
- August 9
As infectious diseases remain a key risk for the region, having learned from the Covid-19 pandemic, insurers must not take eyes off the ball.
-
China revises emergency response law to alleviate nat cat shocks
- June 30
The revised law calls for the establishment of a nat cat risk insurance system based on market principles, and instruct local governments to take out personal accident insurance for rescue teams.
-
Union Insurance’s capital restored to pre-Covid levels: AM Best
- May 30
AM Best affirmed its financial strength rating of "A-" (excellent) with a stable outlook, citing a very strong balance sheet and adequate operating performance.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
